Skip to content

Adaptive Topology-Semantic Fusion Contrastive Learning for Drug Repositioning.

Sep 2026 · Journal of Chemical Information and Modeling · Vol 66 17, pp. 10635-10647 · 0 citations · 43 references
Medicine

TL;DR

ATSFCL-DR provides an effective approach for drug-disease association prediction and candidate drug screening by adaptively integrating topological and semantic information within a contrastive learning framework.

Abstract

Drug repositioning offers an efficient alternative to de novo drug development; however, accurately identifying potential drug-disease associations remains challenging. Existing methods do not fully exploit higher-order collaborative information at the drug-drug and disease-disease levels, and their feature fusion strategies are often static, lacking adaptability to node-specific differences. To address these limitations, we propose ATSFCL-DR, an adaptive topology-semantic fusion contrastive learning framework for drug repositioning. The method constructs a topology graph and a semantic graph, and introduces an adaptive fusion strategy to integrate node representations learned from these two views, thereby enabling more effective use of higher-order information. In addition, the framework designs a multiview fusion contrastive learning mechanism to enhance the consistency and discriminative ability of cross-view representations. To mitigate the noise introduced during higher-order neighborhood aggregation, the framework further incorporates a layer-level contrastive learning objective to improve the robustness of representation learning. Experiments using 10 repetitions of 10-fold cross-validation on three public benchmark data sets show that ATSFCL-DR outperforms representative baseline methods, achieving an average AUROC of 0.9093 and an average AUPR of 0.5362. Furthermore, by predicting previously unknown drug-disease associations on the Gdata set and validating them against authoritative databases, ATSFCL-DR identifies pramipexole as a promising candidate drug for Alzheimer's disease. In summary, ATSFCL-DR provides an effective approach for drug-disease association prediction and candidate drug screening by adaptively integrating topological and semantic information within a contrastive learning framework.

View source

Similar papers

Open access Sep 2026

HFEDTI: A DTI Prediction Model Integrating Local–Global Feature Fusion and Weighted Ensemble Learning

HFEDTI is proposed, a DTI prediction model that integrates hierarchical feature fusion and weighted ensemble learning that consistently achieves strong performance on the C. elegans and Human datasets, further validating its effectiveness and generalization capability for DTI prediction.

Qing-Chuan Xu, An-Ting Gao, Kai Che et al. · 0 citations
Sep 2026

DRCMDA: A Dual-View Drug Repositioning Framework with Cluster-Aware Structured Masked Reconstruction and Diffusion-Based Metapath-Graph Augmentation.

Drug repositioning aims to identify new therapeutic indications for existing drugs, yet current deep learning approaches on multi-source biological data face limitations in both homogeneous and heterogeneous network modeling. In homogeneous similarity networks, random masking-based self-supervised learning neglects int...

Shijie Zhang, Xu Zhang, Zhen-Hua Yu et al. · 0 citations
Open access Sep 2026

DIAM: Adaptive Drug Repositioning with Decoupled Biological Mechanism and Instance-Aware Modulation

DIAM is proposed, which establishes a mechanism-adaptive paradigm by explicitly decoupling structural and molecular signals by introducing a Dual-Stream Biological Mechanism Decoupling module to construct global structural propagation and local molecular interaction views explicitly.

Ke-Yuan Xu, Ke-Yuan Xu, Shu-Hui Yin et al. · 0 citations
Open access Sep 2026

Multiscale cross modal fusion and cascaded signal propagation for drug target interaction prediction

SF-DTI is a unified framework that integrates multi-encoder protein fusion, structure-semantic drug alignment, and progressive cross-modal refinement for DTI prediction and may support virtual screening, drug repositioning, and drug discovery.

Bo-Wen Wang, Xiao-Lan Xie, Hai-Tao Zou et al. · 0 citations
#artificial intelligence Preprint Aug 2026

DPTM-DT: Dual-Pretrained Transformer Multitask Representation Learning for Drug-Target Prediction

Drug-target relation prediction supports candidate screening, drug repositioning, and mechanism analysis. Existing models often use incomplete drug or protein representations, model cross-modal interactions shallowly, or train affinity regression and interaction classification separately, although these tasks describe...

Ge Kong · 0 citations
Open access Sep 2026

FKAN-MoCBDTI: Multimodal drug-target interaction prediction via collaborative bilinear attention and knowledge distillation.

Drug-target interaction (DTI) prediction plays a pivotal role in drug discovery and drug repurposing, yet current deep learning approaches still suffer from limitations in multimodal fusion, fine-grained cross-modal interaction modeling, nonlinear representation learning, and inductive generalization. To overcome these...

Xian-Jun Hu, Zhen Zhang, Zi-Yan Deng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.